cancer

November 5, 2024

Burning Cancer’s Bridges

A newly developed antibody-based treatment for the most aggressive type of breast cancer could also be used to treat many other cancers new Weizmann Institute of Science research shows. “Build...

eastRead More

September 10, 2024

Both Faster and Stronger

A new Weizmann Institute of Science approach promises to advance cancer immunotherapy by increasing the proliferation rate of cancer-targeting immune cells while retaining their ability to kill cancer cells. Cellular...

eastRead More

August 31, 2024

Peeling Back the Layers of Brain Tumours

Weizmann Insitute scientists have mapped common types of brain tumours at unprecedented resolution – and identified a possible reason why some patients fail to respond to a new drug. The...

eastRead More

August 14, 2024

Sticking a Pin in Cancer

A new cellular mechanism for identifying unravelled proteins, discovered by scientists at the Weizmann Institute of Science and recently published in Molecular Cell, may serve as a target for cancer...

eastRead More

July 2, 2024

A Sweet New MRI Method ‘Lights Up’ Pancreatic Cancer

Altered glucose digested by cancer cells helps reveal tumours’ hiding places, new research at the Weizmann Insitute of Science shows. Pancreatic cancer is difficult to detect, in part because the...

eastRead More

January 23, 2024

Standing United: When Immune Cells Join Forces, Cancer Therapy Is More Effective

A new kind of immunotherapy, based on crosstalk between different immune cells, could pave the way for innovative treatments of cancer and autoimmune diseases Winning on the battlefield takes a...

eastRead More

August 9, 2023

A Select Group: Study May Bring Improved Therapy to Preselected Lung Cancer Patients

Researchers at the Weizmann Institute of Science have identified a biomarker that may one day enable a subgroup of lung cancer patients to benefit from relapse-free treatment. Non-smokers who develop...

eastRead More

March 6, 2023

Immunotherapy Drugs Step on the Gas

Sometimes anticancer antibodies press on the gas and the brakes at the same time. New research from the Weizmann Institute of Research in Israel might help them accelerate better. When...

eastRead More

November 18, 2022

Weizmann Institute scientists reveal how viruses outwit cellular immune systems

We are used to thinking of the immune system as a separate entity, almost a distinct organ, but the truth is much more complicated. Breakthroughs in recent years – some...

eastRead More

September 30, 2022

Human Tumours Are Prized Real Estate for Fungi, Study Finds

Cancer tumours contain multiple species of fungi that differ per tumour type, according to a large study led by researchers at the Weizmann Institute of Science and the University of...

eastRead More

September 9, 2022

Putting Liquid Biopsies on Solid Ground: Cancer Diagnosis from a Millilitre of Blood

Blood tests – simple, noninvasive and economically feasible – promise to become the next major milestone in cancer diagnosis. However, most of these tests, dubbed liquid biopsies, are currently not...

eastRead More

March 24, 2022

Antibodies Fight Cancer Too

Immunotherapies for cancer rely on recruiting the patient’s immune system, but they still fall far short of tapping into the entire arsenal of the body’s natural defences. In fact, most...

eastRead More

June 27, 2021

An Unusual Way to Die

New research that reveals the details of an alternative cell death may lead to new therapies for a variety of diseases. Unlikely causes of death, like lightning, may strike out...

eastRead More

February 28, 2021

Uncovering the Anti-Myeloma Resistance Files

Multiple myeloma patients live much longer today than in the past, thanks to new targeted anti-myeloma drugs, but ultimately most develop resistance to the medications, and in some the disease...

eastRead More

December 20, 2020

How Cancers Hurt Themselves to Hurt Immune Cells More

A study of melanoma cells explains a puzzling response they exhibit to ward off T cell attacks.  Cancers like melanoma are hard to treat, not least because they have a...

eastRead More

August 12, 2020

New Method Sees Into More Cells Than Ever Before

A new technology developed at the Weizmann Institute of Science may help answer outstanding questions about the immune system, cancer, Alzheimer’s, and more. Invading cells’ private space – prying into...

eastRead More

July 22, 2020

A New Approach to Tailoring Cancer Therapy: Tapping into Signalling Activities in Cancer Cells

Choosing the right drug for each cancer patient is key to successful treatment, but currently physicians have few reliable pointers to guide them in designing treatment protocols. Researchers at the...

eastRead More

February 19, 2020

Predicting Immunotherapy Success

One of the frustrations with anti-cancer therapy is that no one drug fits all: Most work well in some people but have little effect in other patients with the same...

eastRead More

September 16, 2019

Cancer Protocols: A New Approach to Predicting Treatment Outcomes

New Weizmann Institute of Science research shows heterogeneity in melanoma tumours prevents effective immune responses. Diversity – at least among cancer cells – is not a good thing. Weizmann research...

eastRead More

May 22, 2019

The ‘Hippo Pathway’ Keeps Cancer at Bay

A cancer research project conducted recently at the Weizmann Institute of Science evokes an unusual image: hippos. The research is not about the weighty, mud-basking mammals, but about the ‘Hippo...

eastRead More